The Centers for Medicare and Medicaid Services has put at least one of the controversial elements of a pending Medicaid pricing rule on hold.
Key Takeaways
-
CMS will not move forward with a proposal to lower the best price in Medicaid by adding together all the drug discounts provided to different members in the supply chain.
The agency will not finalize its proposal to calculate Medicaid “best prices” by adding all the discounts and rebates on...







